 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 3 | 1/1 | 返回列表 |
| 查看: 489 | 回復(fù): 2 | |||
審雨堂88銀蟲 (初入文壇)
|
[求助]
求助-湯森路透藥物報告 已有1人參與
|
|
求助Arbidol的湯森路透藥物報告，謝謝！ [ Last edited by 審雨堂88 on 2014-2-27 at 09:55 ] |
回復(fù)此樓» 猜你喜歡
計算化學(xué)與人工智能驅(qū)動的MOFs性能預(yù)測與篩選技術(shù)
已經(jīng)有0人回復(fù)
-
研三實驗求指導(dǎo)
已經(jīng)有0人回復(fù)
-
藥物學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有165人回復(fù)
-
金屬材料多尺度計算模擬技術(shù)與應(yīng)用：微觀機(jī)理到宏觀性能的集成工作
已經(jīng)有0人回復(fù)
-
使用MolAICal進(jìn)行多肽虛擬篩選教程-同樣適用于蛋白質(zhì)和核酸的虛擬篩選
已經(jīng)有1人回復(fù)
-
使用MolAICal計算藥物化學(xué)過濾器MCFs及MCE-18描述符
已經(jīng)有0人回復(fù)
-
使用MolAICal發(fā)現(xiàn)蛋白受體潛在的活性口袋及位點
已經(jīng)有0人回復(fù)
-
華理藥學(xué)學(xué)碩求調(diào)劑，總分324
已經(jīng)有0人回復(fù)
-
江西科技師范大學(xué)微生物天然藥物老師介紹
已經(jīng)有23人回復(fù)
-
澳門理工大學(xué)人工智能藥物發(fā)現(xiàn)中心招收2026級博士研究生（申請-考核制）
已經(jīng)有10人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- 湯姆森數(shù)據(jù)庫求助
已經(jīng)有7人回復(fù)
- 求助一個湯姆森報告
已經(jīng)有3人回復(fù)
- 求助索利那新（solifenacin）和帕立骨化醇（paricalcitol） 的湯森路透報告
已經(jīng)有8人回復(fù)
- 湯森路透2014需要重點關(guān)注的藥物
已經(jīng)有449人回復(fù)
- 湯森路透-藥物化學(xué)在研發(fā)角色的轉(zhuǎn)變（2013年6月7日 ）【已搜索無重復(fù)】
已經(jīng)有164人回復(fù)
- 求：2013版的抗高血壓藥物市場研究報告~
已經(jīng)有5人回復(fù)
- 臨床前研究指南（CFDA和FDA，新的和舊的，共四個）
已經(jīng)有206人回復(fù)
- 求助湯森路透藥物研究報告
已經(jīng)有4人回復(fù)
- 求助關(guān)于藥物對照品的問題
已經(jīng)有18人回復(fù)
- 糖尿病藥物市場調(diào)查報告 2012
已經(jīng)有135人回復(fù)
- 降血脂藥物市場研究報告（2012年版）
已經(jīng)有411人回復(fù)
- 【求助】緩釋制劑臨床試驗
已經(jīng)有11人回復(fù)
- 【求助】請問醫(yī)藥信息調(diào)研報告包括哪些方面的內(nèi)容？
已經(jīng)有20人回復(fù)
- 【求助】有關(guān)中藥資源調(diào)查報告的問題
已經(jīng)有5人回復(fù)
- 【求助】求助一篇調(diào)查報告
已經(jīng)有9人回復(fù)
- 【求助】##藥物生產(chǎn)工藝技術(shù)可行性報告怎么寫
已經(jīng)有5人回復(fù)
- 【求助】想學(xué)計算機(jī)輔助藥物設(shè)計
已經(jīng)有28人回復(fù)
hlchenbetter
鐵桿木蟲 (正式寫手)
- 應(yīng)助: 2 (幼兒園)
- 金幣: 11540.6
- 紅花: 1
- 帖子: 311
- 在線: 162.6小時
- 蟲號: 1060733
- 注冊: 2010-07-19
【答案】應(yīng)助回帖
★ ★ ★ ★ ★
感謝參與，應(yīng)助指數(shù) +1
審雨堂88: 金幣+5, ★有幫助, 謝謝 2014-02-27 16:02:09
感謝參與，應(yīng)助指數(shù) +1
審雨堂88: 金幣+5, ★有幫助, 謝謝 2014-02-27 16:02:09
|
Accession No: 18965 Main Details Drug Name World Status Pharma Status Arbidol Launched Fully Launched Latest Change Updated On By Latest Change 3 Jun 1994 UN Minor change Company Status Data Originator Country Development Stage Non-industrial source Unspecified Launched Activity Data Therapy Description Code Therapy Status Immunostimulant, other I1Z Launched Antiviral, other J5Z Launched Pharmacology Description Code Immunostimulant IM+ Therapy Code Pharmacology Code I1Z J5Z IM+ IM+ Route of Administration Route of Administration Code Alimentary, po A-PO Indication Indication Status Infection, influenza virus Launched Target Data Target Name LocusLink/Entrez Gene ID Unspecified Unspecified -------------------------------------------------------------------------------- Target Family Group(s) Receptor > Cytokine receptor > Class II Chemical Data Origin of Material Code Description CH-SY Chemical, synthetic CAS Registry Number Rotatable Bonds Molecular Formula 131707-23-8 9 C22H26BrClN2O3S Hydrogen Bond Acceptors Hydrogen Bond Donors AlogP Molecular Weight 6 1 4.50 477.42 Chemical Name 1H-indole-3-carboxylic acid, 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-, ethylester, monohydrochloride [CAS] Structure New Chemical Entity Yes Patent Data Country Number Priority Country Priority Date WO 9008135 WO 12 January 1989 Country Data Country Name Country Status Year Launched Licensing Op. Argentina - Yes Australia - Yes Austria - Yes Belgium - Yes Brazil - Yes Canada - Yes Chile - Yes China - Yes Colombia - Yes Denmark - Yes Finland - Yes France - Yes Germany - Yes Greece - Yes Hong Kong - Yes India - Yes Ireland - Yes Israel - Yes Italy - Yes Japan - Yes Luxembourg - Yes Malaysia - Yes Mexico - Yes Netherlands - Yes New Zealand - Yes Norway - Yes Peru - Yes Philippines - Yes Portugal - Yes Russian Federation Launched Yes South Africa - Yes South Korea - Yes Spain - Yes Sweden - Yes Switzerland - Yes Thailand - Yes Turkey - Yes UK - Yes USA - Yes Venezuela - Yes Major Events Event Date Act/Est Event Details 15 Oct 1992 Est New Product in Pharmaprojects 15 Oct 1992 Est Licensing Opportunities Worldwide Ratings Novelty Market Size Speed Total Established Strategy (2) US$ 0-500 million (1) Not available (0) Not available Detailed Information Arbidol is an interferon-inducer, developed by Dr I S Nikolaeva of the Centre for Chemistry of Drugs, VNIKhFI, Zubovskay Street 7, Moscow 119517, Russia, as a therapeutic and prophylactic for influenza A and B and other respiratory viral infections (Personal communication, Sep 1992). Marketing It is launched in Russia for therapeutic use in influenza A and B. Clinical Phase III In 2000 influenza patients, Arbidol 0.2g po tid or qid for 3 days reduced the duration of fever, catarrhal syndrome and overall disease, and prevented the development of post-influenzal complications. A prophylactic effect was achieved by 100mg twice/wk. It had an efficacy index of 5.16 (cf 1.0 for ramantadine) (18th Int Cong Chemother (Stockholm), 1993, Abs 190; Personal communication, Jun 1993). In 12 volunteers, 300mg/kg po produced interferon titres of 160IU/ml 24hr after administration (4th BICON (Prague), 1992, Abs 155). Preclinical In cell culture, it inhibited the plaque-forming activity of influenza virus without affecting its haemagglutinating activity. Licensing Arbidol is available for licensing worldwide (Personal communication, Sep 1992). |
2樓2014-02-27 10:17:11
審雨堂88
銀蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 300.4
- 帖子: 48
- 在線: 152.8小時
- 蟲號: 1062270
- 注冊: 2010-07-22
- 專業(yè): 民族藥學(xué)
3樓2014-02-27 10:41:51
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 審雨堂88 的主題更新
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 298-一志愿中國農(nóng)業(yè)大學(xué)-求調(diào)劑 +11 | 手機(jī)用戶 2026-03-17 | 12/600 |
|
|---|---|---|---|---|
|
|
[考研] 求材料，環(huán)境專業(yè)調(diào)劑 +3 | 18567500178 2026-03-18 | 3/150 |
|
|
|
[考研] 279分求調(diào)劑 一志愿211 +17 | chaojifeixia 2026-03-19 | 19/950 |
|
|
|
[考研] 335分 | 材料與化工專碩 | GPA 4.07 | 有科研經(jīng)歷 +4 | cccchenso 2026-03-23 | 4/200 |
|
|
|
[考研] 一志愿武理材料工程348求調(diào)劑 +6 | ￣^￣゜汗 2026-03-19 | 9/450 |
|
|
|
[考研] 北科281學(xué)碩材料求調(diào)劑 +8 | tcxiaoxx 2026-03-20 | 9/450 |
|
|
|
[考研] 311求調(diào)劑 +6 | 冬十三 2026-03-18 | 6/300 |
|
|
[考研] 材料與化工085600，總分304，本科有兩篇sci參與，求調(diào)劑 +4 | 幸運(yùn)的醬醬 2026-03-22 | 5/250 |
|
|
|
[考研] 一志愿華中農(nóng)業(yè)071010，總分320求調(diào)劑 +5 | 困困困困坤坤 2026-03-20 | 6/300 |
|
|
|
[考研] 求調(diào)劑 +4 | 要好好無聊 2026-03-21 | 4/200 |
|
|
|
[考研] 二本跨考鄭大材料306英一數(shù)二 +3 | z1z2z3879 2026-03-17 | 3/150 |
|
|
|
[考研] 085700資源與環(huán)境308求調(diào)劑 +12 | 墨墨漠 2026-03-18 | 13/650 |
|
|
|
[考研] 一志愿武理材料305分求調(diào)劑 +6 | 想上岸的鯉魚 2026-03-18 | 7/350 |
|
|
|
[考研] 一志愿西南交大，求調(diào)劑 +5 | 材化逐夢人 2026-03-18 | 5/250 |
|
|
|
[考研] 308求調(diào)劑 +3 | 阿姐阿姐家啊 2026-03-18 | 3/150 |
|
|
|
[考研] 290求調(diào)劑 +7 | ^O^乜 2026-03-19 | 7/350 |
|
|
|
[考研] 一志愿西南交通 專碩 材料355 本科雙非 求調(diào)劑 +5 | 西南交通專材355 2026-03-19 | 5/250 |
|
|
|
[考研] 求調(diào)劑 +3 | @taotao 2026-03-20 | 3/150 |
|
|
|
[考研] 一志愿南理工085701環(huán)境302求調(diào)劑院校 +3 | 葵梓衛(wèi)隊 2026-03-20 | 3/150 |
|
|
|
[考研] 288求調(diào)劑，一志愿華南理工大學(xué)071005 +5 | ioodiiij 2026-03-17 | 5/250 |
|